Jennison Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

Jennison Associates’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-75,122	Closed	-$6.24M	–	724
2020 Q1	$6.24M	Sell	75,122 -52,604	-41%	-$5.13M	0.01%	377
2019 Q4	$14.2M	Hold	127,726	–	–	0.01%	347
2019 Q3	$12.7M	Sell	127,726 -157,823	-55%	-$15.7M	0.01%	373
2019 Q2	$28.3M	Sell	285,549 -405,443	-59%	-$38.7M	0.03%	294
2019 Q1	$76.2M	Sell	690,992 -175,739	-20%	-$18.4M	0.08%	154
2018 Q4	$79.7M	Buy	866,731 +32,581	+4%	+$3.3M	0.09%	132
2018 Q3	$91.9M	Buy	834,150 +208,156	+33%	+$21.7M	0.08%	156
2018 Q2	$58.4M	Buy	625,994 +611,949	+4,357%	+$52.7M	0.06%	241
2018 Q1	$1.17M	Buy	14,045 +2,843	+25%	+$253K	﹤0.01%	555
2017 Q4	$1.02M	Buy	11,202 +7,894	+239%	+$657K	﹤0.01%	579
2017 Q3	$252K	Buy	+3,308	New	+$250K	﹤0.01%	646

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Jennison Associates's PRAH Position: Q2 2020 in Review

Jennison Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 75,122 shares — an estimated $6.24M sold.

Jennison Associates first reported a position in PRAH in Q3 2017 and held it in 11 quarters. The position peaked at $91.9M in Q3 2018. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

Jennison Associates reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
Jennison Associates sold 75,122 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $6.24M.
Jennison Associates first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 11 quarters.
Jennison Associates's PRA Health Sciences, Inc. position peaked at $91.9M in Q3 2018.
293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Jennison Associates's 13F filing for Q2 2020, filed 6 Aug 2020.